News for Novartis AG

Seeking Alpha 3d

Bristol Myers, Gilead, J&J, Novartis win favorable FDA label updates for cell therapies

Seeking Alpha 33d

Alvotech and Advanz Pharma add three more biosimilars to collaboration

Seeking Alpha 38d

Global cancer drug sales growth to slow amid patent cliffs: report

Seeking Alpha 47d

Incyte and Novartis settle royalties dispute related to Jakafi

Seeking Alpha 77d

Trump says pharma tariffs are coming in the “not-too-distant-future”

Seeking Alpha 77d

Amgen faces antitrust lawsuit from Sandoz over Enbrel patents

Seeking Alpha 81d

Novartis is eyeing $23B investment in U.S.

Seeking Alpha 93d

Trump’s medical tariffs could significantly hurt these European healthcare firms

Seeking Alpha 125d

Novartis pulls back after report on Emasan share offering

Seeking Alpha 150d

Novartis delays Phase 3 readout for Ionis heart drug

Seeking Alpha 150d

Novartis proposes dividend raise to CHF 3.50

Seeking Alpha 150d

Earnings Snapshot: Novartis tops Q4 estimates; projects continued momentum in 2025

Seeking Alpha 151d

Novartis beats Q4 top-line and bottom-line estimates; initiates FY25 soft outlook

Seeking Alpha 152d

Royalty Pharma completes sale of MorphoSys bonds

Seeking Alpha 163d

Chinese biotech dominance in R&D is on the rise

Seeking Alpha 168d

Schrödinger receives regulatory approval for Novartis collaboration

Seeking Alpha 221d

Novartis buys gene therapy developer Kate for up to $1.1B

Seeking Alpha 221d

Novartis raises mid-term sales guidance

Seeking Alpha 230d

Schrödinger gains on Novartis deal despite Q3 miss

Seeking Alpha 244d

Novartis says more time needed for cancer therapy added with MorphoSys deal

Seeking Alpha 270d

U.S. tweaks 2025 Medicare price negotiation process

Seeking Alpha 272d

Teva launches first U.S. generic against Novartis antidiarrheal Sandostatin LAR

Seeking Alpha 278d

Perspective draws buy at Truist on radiopharma potential

Seeking Alpha 292d

Novartis lower as BofA downgrades on risks to valuation

Seeking Alpha 298d

Novartis licenses gene therapy component from Voyager

Seeking Alpha 299d

Novartis expands U.S. radiopharma production amid rising competition

Seeking Alpha 310d

Siemens Healthineers seeks €200M Novartis deal to boost cancer imaging business: FT

Seeking Alpha 348d

Earnings summary: Novartis beats Q2 earnings estimates; raises FY2024 bottom-line guidance

Seeking Alpha 348d

Novartis beats top-line and bottom-line estimates; raises FY24 core operating income outlook

Markets Insider Automation 348d

Novartis earnings: here's what Wall Street expects

Seeking Alpha 387d

AstraZeneca dominates, Merck’s Keytruda beaten as ASCO 2024 concludes

Seeking Alpha 389d

Novartis, Roche facing Italy antitrust probe over Lucentis biosimilar

Seeking Alpha 398d

Travere gains on Novartis data for Filspari rival, Calliditas buyout

Seeking Alpha 424d

Radiopharma stocks higher as sector welcomes the latest M&A deal

Seeking Alpha 426d

Novo, Teva, AstraZeneca issued FTC warnings over ‘bogus’ patents

Seeking Alpha 429d

Amgen’s Blincyto data send Cullinan higher

Seeking Alpha 434d

Novartis beats top-line and bottom-line estimates; raises FY24 outlook

Markets Insider Automation 434d

Novartis is about to announce its earnings — here's what Wall Street expects

Seeking Alpha 437d

FDA requires labeling changes to CAR-T cell therapies to reflect cancer risk

Seeking Alpha 438d

TG Therapeutics wins VA contract for Briumvi

Seeking Alpha 439d

CVS favors Humira copycats hurting AbbVie’s market share: Evercore

Seeking Alpha 445d

Vertex Pharma upgraded at Evercore on Alpine Immune deal

Seeking Alpha 450d

Bausch Health sues Amneal Pharma over Xifaxan generic

Seeking Alpha 454d

Intra-Cellular files lawsuits challenging Caplyta generics

Seeking Alpha 468d

AstraZeneca-Fusion deal reignites radiopharma space

Seeking Alpha 479d

Merck touts new Keytruda version as patent cliff approaches

Seeking Alpha 479d

IDEAYA a new Buy at BTIG on underappreciated pipeline

Seeking Alpha 482d

Sandoz biosimilars targeting Amgen’s Prolia, Xgeva cleared

Seeking Alpha 486d

Medicare price negotiations survive another legal challenge

Seeking Alpha 491d

Radiopharmaceutical market expected to reach ~$14B by 2032

Novartis Peer Group News

12/11/20	Pfizer falls 2% as FDA nears final authorization of its COVID-19 vaccine
12/01/20	S&P 500 and Nasdaq close at record highs as investors bet that a vaccine will drive an economic rebound
11/18/20	Pfizer and BioNTech climb as 95% vaccine effectiveness tees up application for FDA approval
11/09/20	Gold slides the most in 3 months as encouraging vaccine data boosts risk appetites
09/21/20	Healthcare stocks plunge amid broad market rout as Ruth Bader Ginsburg's death creates uncertainty around Obamacare
08/19/20	Momenta Pharmaceuticals spikes 69% after agreeing to $6.5 billion Johnson & Johnson takeover
07/13/20	Pfizer and BioNTech shares rise after FDA grants 2 coronavirus vaccines 'fast track' status (PFE, BNTX)
07/01/20	Pfizer leaps 6% after releasing positive trial results for coronavirus vaccine

	
		OSZAR »